Organon & Co.
OGN- Exchange
- NYSE
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001821825
No open-market purchases or sales by Organon & Co. insiders were filed in the last 90 days; 638 institutions reported holding it in 13F filings for Q2 2026, worth $2.92B in total; no superinvestor holds it.
Key figures
- Market capClose on Nov 13, 2026
- $3.65B
- Insider buysOpen market, last 90 days
- 0
- Insider sellsOpen market, last 90 days
- 0
- 13F holdersQ2 2026, +30 vs. previous quarter
- 638
- 13F valueReported value at the end of Q2 2026
- $2.92B
- Superinvestors holdingAt the end of Q2 2026
- 0
Price chart
Financials
See financial statementsFrom SEC filings, in USD.
- Revenue, FY2025
- $6.22B
- −2.9% year over year
- Net income, FY2025
- $187.0M
- −78.4% year over year
- Free cash flow, FY2025
- $538.0M
- −29.6% year over year
- Revenue, Q3 FY2026
- $1.57B
- −1.7% year over year
Revenue flow, FY2025
Green is profit; orange is costs, expenses and taxes. Percentages are shares of revenue.
Short interest
See short dataFrom FINRA, settlement date Oct 30, 2026.
- Short interest
- 19.7M
- Shares sold short
- Change
- +876.3K
- +4.7% vs. previous
- Days to cover
- 8.48
- At average daily volume
Superinvestors holding OGN, Q2 2026
Go to the superinvestors tabNo superinvestor reported holding OGN at the end of Q2 2026.
Latest insider trades
See all insider tradesOpen-market purchases and sales by Organon & Co. insiders from Form 4, newest first.
| Filed (ET) | Trade date | Filing delay | Insider | Transaction | Shares | Avg price | Value | Holding change | Flags |
|---|---|---|---|---|---|---|---|---|---|
| Aug 5, 2026 (view filing)4:04 PM ET | Aug 5 | Same day | Drinane Juliana PapaHead of Mfg & Supply | SSale | −14.8K | $13.57 | −$200.3K | −44.4%18.5K after | |
| May 7, 2026 (view filing) | May 6 | 1 day | Holzbaur LynetteSVP and Corporate Controller | SSale | −26.4K | $13.35 | −$353.1K | −100.0%0 after | Amended |
| Nov 13, 2025 (view filing) | Nov 12 | 1 day | Cox Carrie SmithExecutive Chair | PPurchase | +65.4K | $7.67 | +$501.6K | +524.5%77.9K after | |
| May 15, 2025 (view filing) | May 14 | 1 day | Cox Carrie SmithDirector | PPurchase | +12.5K | $8.07 | +$100.6K | New position12.5K after | |
| May 7, 2025 (view filing) | May 7 | Same day | Falcione AaronChief Human Resources Officer | PPurchase | +5.50K | $8.77 | +$48.2K | +9.6%63.0K after | |
| May 7, 2025 (view filing) | May 6 | 1 day | Weaver KirkeGen. Counsel & Corp. Secy. | PPurchase | +8.04K | $9.21 | +$74.1K | +18.1%52.5K after | |
| May 7, 2025 (view filing) | May 6 | 1 day | Karp DanielExecutive VP, Corp. Dev. | PPurchase | +3.50K | $8.24 | +$28.8K | +8.1%46.7K after | |
| May 6, 2025 (view filing) | May 5 | 1 day | Walsh Matthew MChief Financial Officer | PPurchase | +11.4K | $8.82 | +$100.5K | +8.6%144.5K after | |
| May 6, 2025 (view filing) | May 5 | 1 day | Ali KevinChief Executive Officer | PPurchase | +34.0K | $8.81 | +$299.5K | +13.7%282.7K after | |
| Feb 23, 2024 (view filing) | Feb 22 | 1 day | Weaver KirkeGen. Counsel & Corp. Secy. | PPurchase | +2.72K | $18.36 | +$49.9K | +21.8%15.2K after |
Top 10 13F holders, Q2 2026
See all 638 holdersThe largest institutional positions in Organon & Co. at the end of Q2 2026; share changes are against Q1 2026.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| BlackRock, Inc. | 32,056,866 | $434.0M | 0.01% | +339,838+1.1% | Added |
| Pentwater Capital Management LP | 18,100,000 | $245.1M | 1.96% | +18,100,000 | New |
| Vanguard Portfolio Management LLC | 15,132,118 | $204.9M | 0.01% | −6,713,918−30.7% | Reduced |
| Vanguard Capital Management LLC | 11,909,865 | $161.3M | 0.00% | +172,847+1.5% | Added |
| State Street Corp | 9,659,371 | $130.8M | 0.00% | −297,403−3.0% | Reduced |
| Goldman Sachs Group Inc | 5,199,002 | $70.4M | 0.01% | +3,593,677+223.9% | Added |
| UBS Group AG | 4,856,529 | $65.8M | 0.01% | +1,384,950+39.9% | Added |
| Geode Capital Management, LLC | 4,815,610 | $65.2M | 0.00% | +56,273+1.2% | Added |
| Man Group plc | 4,180,500 | $56.6M | 0.10% | +4,180,500 | New |
| CNH Partners LLC | 3,880,354 | $52.4M | 0.75% | +3,880,354 | New |
Holders of 5% or more of OGN
See all 4 holders and filingsHolders whose latest Schedule 13D or 13G filing reports 5% or more of Organon & Co..
| Holder | Latest form | Stake | Change | First filed | Latest filing | Filing |
|---|---|---|---|---|---|---|
| BlackRock, Inc. | 13G/A | 11.90%30.7M shares | – | Apr 30, 20251 filing | Apr 30, 2025 | SEC |
| Pentwater Capital Management LP | 13G | 6.90%18.1M shares | New | Aug 14, 20261 filing | Aug 14, 2026 | SEC |
| Vanguard Portfolio Management LLC | 13G/A | 5.77%15.2M shares | −2.70 ppfrom 8.47% | Apr 29, 20262 filings | Jul 31, 2026 | SEC |
| Vanguard Capital Management LLC | 13G | 5.26%13.7M shares | New | Apr 30, 20261 filing | Apr 30, 2026 | SEC |
Politician trades
All politician trades in OGN3 members of Congress reported 3 trades in Organon & Co. since 2020. Newest filings:
| Filed | Politician | Type | Amount |
|---|---|---|---|
| Aug 12, 2026 |  Kevin Hern House · OK | Sell | $1K-$15K |
| Nov 24, 2025 |  Gary C. Peters Senate · MI | Sell (full) | $1K-$15K |
| Jul 9, 2021 |  John W. Hickenlooper Senate · CO | Sell (full) | $1K-$15K |
House · OK · Aug 12, 2026
Sell$1K-$15K
Senate · MI · Nov 24, 2025
Sell (full)$1K-$15K
Senate · CO · Jul 9, 2021
Sell (full)$1K-$15K